Kailera Therapeutics, INC. 3 Filing
Ticker: KLRA · Form: 3 · Filed: Apr 16, 2026 · CIK: 0002096997
Sentiment: neutral
Filing Details
This Initial Statement of Beneficial Ownership (Form 3) was filed with the SEC on April 16, 2026 regarding Kailera Therapeutics, Inc. (KLRA). Form 3 filings establish the initial ownership position of company insiders when they first assume their role.